Increased plasma S100A12 (EN-RAGE) levels in patients with diabetic nephropathy

被引:0
|
作者
Kosaki, A
Uchiyama-Tanaka, Y
Mori, Y
Hasegawa, T
Inoue-Shibata, M
Nishikawa, MS
Iwasaka, T
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A201 / A201
页数:1
相关论文
共 50 条
  • [1] Increased Plasma S100A12 (EN-RAGE) Levels in Hemodialysis Patients with Atherosclerosis
    Mori, Yasukiyo
    Kosaki, Atsushi
    Kishimoto, Noriko
    Kimura, Tatsuji
    Iida, Kumiko
    Fukui, Masayoshi
    Nakajima, Fumitaka
    Nagahara, Masayuki
    Urakami, Masaya
    Iwasaka, Toshiji
    Matsubara, Hiroaki
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (01) : 18 - 24
  • [2] Increased plasma EN-RAGE (S100A12) levels in patients with type 2 diabetes
    Kosaki, A
    Hasegawa, T
    Kimura, T
    Hitomi, J
    Matsubara, H
    Nishikawa, S
    Iwasaka, T
    [J]. DIABETES, 2002, 51 : A158 - A158
  • [3] Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes
    Kosaki, A
    Hasegawa, T
    Kimura, T
    Iida, K
    Hitomi, J
    Matsubara, H
    Mori, Y
    Okigaki, M
    Toyoda, N
    Masaki, H
    Inoue-Shibata, M
    Nishikawa, M
    Iwasaka, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (11): : 5423 - 5428
  • [4] S100A12 (EN-RAGE) in monitoring Kawasaki disease
    Foell, D
    Ichida, F
    Vogl, T
    Yu, XY
    Chen, R
    Miyawaki, T
    Sorg, C
    Roth, J
    [J]. LANCET, 2003, 361 (9365): : 1270 - 1272
  • [5] Expression of S100A12 (EN-RAGE) in cystic fibrosis
    Foell, D
    Seeliger, S
    Vogl, T
    Koch, HG
    Maschek, H
    Harms, E
    Sorg, C
    Roth, J
    [J]. THORAX, 2003, 58 (07) : 613 - 617
  • [6] Pathophysiological role of plasma EN-RAGE (S100A12) protein in patients with Type 2 diabetes
    Kosaki, A
    Hasegawa, T
    Kimura, T
    Hitomi, J
    Matsubara, H
    Inoue-Shibata, M
    Nishikawa, M
    Iwasaka, T
    [J]. DIABETOLOGIA, 2003, 46 : A374 - A375
  • [7] Serum S100A12 (EN-RAGE) Levels in Patients with Decreased Renal Function and Subclinical Chronic Inflammatory Disease
    Zakiyanov, Oskar
    Kalousova, Marta
    Kriha, Vitezslav
    Zima, Tomas
    Tesar, Vladimir
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2011, 34 (06): : 457 - 464
  • [8] Total chemical synthesis and chemotactic activity of human S100A12 (EN-RAGE)
    Miranda, LP
    Tao, T
    Jones, A
    Chernushevich, I
    Standing, KG
    Geczy, CL
    Alewood, PF
    [J]. FEBS LETTERS, 2001, 488 (1-2): : 85 - 90
  • [9] CIRCULATING S100A12 (EN-RAGE), SOLUBLE RAGE, AND MORTALITY IN CHRONIC KIDNEY DISEASE STAGE 5 PATIENTS
    Isoyama, Naohito
    Leurs, Paul
    Qureshi, Abdul Rashid
    Anderstam, Bjorn
    Heimburger, Olof
    Barany, Peter
    Stenvinkel, Peter
    Lindholm, Bengt
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 407 - 407
  • [10] Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin
    Larsen, A.
    Bronstein, I. B.
    Dahl, O.
    Wentzel-Larsen, T.
    Kristoffersen, E. K.
    Fagerhol, M. K.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2007, 65 (02) : 192 - 201